Carazolol

Summary

Carazolol is a high affinity inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.[1]

Carazolol
Clinical data
AHFS/Drugs.comInternational Drug Names
ATCvet code
Identifiers
  • 1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
CAS Number
  • 57775-29-8
PubChem CID
  • 71739
IUPHAR/BPS
  • 569
ChemSpider
  • 64783
UNII
  • 29PW75S82A
ChEMBL
  • ChEMBL324665
CompTox Dashboard (EPA)
  • DTXSID00866648 Edit this at Wikidata
ECHA InfoCard100.055.387 Edit this at Wikidata
Chemical and physical data
FormulaC18H22N2O2
Molar mass298.386 g·mol−1
3D model (JSmol)
  • Interactive image
  • OC(CNC(C)C)COc3cccc2c3c1c(cccc1)[nH]2

References edit

  1. ^ Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi:10.1016/0024-3205(79)90102-4. PMID 41147.

External links edit